ABCB Ameris Bancorp

NYSE
$79.74

Ameris Bancorp Faces a Margin Test as Shares Sag Toward Post-Earnings Lows

Ameris Bancorp heads into its third-quarter report with a fundamental story that management insists is getting better and a stock price that says the market is not convinced. Last quarter the Southeast lender posted its strongest loan production in at least a year, entered Nashville, and kept credit clean. It also absorbed an $82.5 million litigation accrual and, for the first time, acknowledged that the net interest margin compression it had long warned about is actually arriving. The October 22 release, due after the close, will show which of those two narratives carries more weight.

The Street is looking for earnings of $1.68 per share, up from $1.60 on an adjusted basis last quarter and about 9.8% above the $1.53 earned a year ago. That is respectable growth for a regional bank, and it implies a sequential improvement despite a guided dip in margin. Consensus revenue of $326.7 million, which would mark a 24% decline from the year-ago figure, looks jarring, but that gap likely reflects differences in how revenue is being measured rather than a collapse in the business, so earnings per share is the cleaner gauge. The real question is how Ameris gets from $1.60 to $1.68 if the margin is easing.

The answer has to come from balance sheet growth and fee stability. Loan production reached $2.4 billion last quarter, up 24% from a year earlier, and average earning assets grew at an 8.5% annualized pace. Management reaffirmed mid-single-digit loan and deposit growth and said it felt more encouraged about growth than it had in a long time, across all its markets and business lines. Validation this quarter would look like loan balances continuing to climb at roughly that pace, the $2.7 billion pipeline converting rather than drifting lower, and early signs that the Nashville banker team is booking business. A pipeline that shrinks again, or production that cools back toward the $2.0 billion level of a year ago, would undercut the idea that volume can outrun margin pressure.

The margin itself is the biggest swing factor. The 3.88% reported last quarter was flattered by roughly three basis points from one-time bond repositioning gains, and management guided to a few basis points of compression per quarter over the next couple of quarters. A decline in that range would be on script. A sharper drop would raise questions about deposit costs, particularly after brokered deposits jumped $174 million to 6.7% of the total to cover seasonal public fund outflows. Investors should want to see brokered funding stabilize or recede as public funds return, and the noninterest-bearing deposit share hold near 30%. On the fee side, mortgage revenue softened last quarter and management tied any rebound to rate relief, so mortgage is better viewed as a source of downside risk than of upside. The adjusted efficiency ratio, which crept to 50.4%, should stay close to the slightly-above-50% guidance; a move further up would erode the positive operating leverage that has defined the story. Net charge-offs inside the 20 to 25 basis point guidance would keep credit off the worry list.

The market has clearly leaned toward skepticism. Shares have fallen 9.3% since the last report while the S&P 500 gained 5.4%, and sentiment has grown noticeably more bearish than it was heading into the prior quarter. At $78.92, the stock sits below its 200-day moving average of $83.42 and just above its post-report low of $78.21, well beneath the $81.94 to $93.22 range of the prior period. That suggests a cautious bar, though a weak tape can also punish any confirmation of margin slippage.

Ultimately, this report comes down to whether loan growth and cost discipline can absorb the margin compression management has already flagged. If Ameris delivers growth near the top of its range with only modest margin erosion and steadier funding, the recent selloff may look overdone. If the margin falls faster than promised or brokered deposits keep rising, the bears will have their evidence.

← Back to ABCB news